Arcadia Biosciences Return on Equity

Arcadia Biosciences (RKDA) currently reports a ROE of -1758.45%. That is below the Materials sector average of 19.67%. Use the charts on this page to explore Arcadia Biosciences's ROE history and peer comparisons.

Arcadia Biosciences's ROE of -1758.45% is lower than the Materials sector average of 19.67%. That is roughly 9038.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Arcadia Biosciences's current -1758.45% should be judged against Materials norms (sector average: 19.67%) and against RKDA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -1758.45%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Materials average is 19.67%. From there, open related valuation or income-statement pages for Arcadia Biosciences, and consider following RKDA for alerts when major investors trade the stock.

Arcadia Biosciences is classified in the Materials sector. On ROE, it currently shows -1758.45% versus a sector average near 19.67%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Materials are usually more informative than comparing RKDA with unrelated industries.